The Peregrine System™ Infusion Catheter (Peregrine Catheter)
The Peregrine Catheter uses a proprietary, patent-pending technology to deliver diagnostic and therapeutic agents directly to the perivascular space that surrounds blood vessels. The catheter is CE marked for the infusion of a neurolytic agent to achieve a reduction in systemic blood pressure in hypertensive patients.
Targeted Perivascular Delivery of Solutions
The Peregrine System Infusion Catheter features three guided microneedles for targeted infusion. The catheter is delivered into the femoral artery utilizing techniques similar to coronary or peripheral catheterization. During endovascular catheter placement, the microneedles remain retracted within radiopaque guide tubes, enabling fluoroscopic confirmation of catheter positioning and apposition of the guide tubes prior to delivery of the diagnostic or therapeutic solution. Once positioning and apposition has been confirmed, all three micro-needles are deployed simultaneously for controlled delivery of the diagnostic or therapeutic agents directly into the perivascular space.
The company has completed pre-clinical and clinical studies of the Peregrine Catheter. Data generated to date is from pre- and post-market clinical studies using the Peregrine Catheter under the CE mark with a neurolytic agent (i.e. alcohol).
The Peregrine System Infusion Catheter is CE marked for the infusion of a neurolytic agent to achieve a reduction in systemic blood pressure in hypertensive patients.